VKTX Viking Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 29, 2026
$29,94
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$26,89mínimo 52 semanas
$43,15máximo 52 semanas
Capitalización Bursátil (MRQ)
$3.49B
P/E (TTM)
-6.4
BPA (TTM)
$-4.67
Ingresos (TTM)
$0
tus insignias
Rango 52S
$27–$43
Calificación del Analista
BUY
Precio Objetivo
$95
P/E
-6.4
ROE
-88.9%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
VKTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$29.94
Capitalización Bursátil (MRQ)
$3.49B
P/E (TTM)
-6.4
BPA (TTM)
$-4.67
Ingresos (TTM)
$0
ROE (TTM)
-88.9%
Rango 52S
$27–$43
VKTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02016-12-31 → 2025-12-31
BPA$-3.192021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | VKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -6.4promedio 5A ≈-17.6 | ≈-17.6 | · | · | |
| P/C (MRQ) | 8.6promedio 5A ≈4.7 | ≈4.7 | 4.0 | Sobrevalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | -12.3promedio 5A ≈-22.8 | ≈-22.8 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 5.4promedio 5A ≈4.7 | ≈4.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | VKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA (TTM) | -79.2%promedio 5A ≈-30.7% | ≈-30.7% | -17.4% | Débil | |
| ROE (TTM) | -88.9%promedio 5A ≈-32.9% | ≈-32.9% | -29.1% | Débil | |
| ROIC | -61.6% | · | -14.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | VKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 4.7promedio 5A ≈18.6 | ≈18.6 | 9.0 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 2.2promedio 5A ≈2.1 | ≈2.1 | 4.0 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | VKTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.3 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-23.1%
Próximo informe
Oct 20, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 21, 2026 | $-1.10 | $-1.27 | 13.5% |
| 31 de marzo de 2026 | $-1.37 | $-1.03 | -32.5% | |
| 31 de diciembre de 2025 | $-1.38 | $-0.91 | -51.3% | |
| 30 de septiembre de 2025 | $-0.81 | $-0.69 | -17.2% | |
| 30 de junio de 2025 | $-0.58 | $-0.46 | -27.4% | |
| 31 de marzo de 2025 | $-0.41 | $-0.33 | -23.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.57 | $7.89 | $3.48 | $1.86 | $2.58 | $3.34 | $3.83 | $4.15 | $0.38 | $0.39 | $0.90 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.47 | $-0.81 | $-0.78 | $-0.63 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.44 | $0.24 | $0.55 | $0.47 | $0.34 | $0.40 | $0.12 | $0.35 | $0.25 | $0.15 | $0.08 | · | |
| EPS (TTM) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.50 | $4.33 | · | $6.34 | $7.08 | $7.54 | · | $8.18 | $8.31 | $8.47 | $3.68 | $3.86 | $1.69 | $1.97 | $2.15 | $2.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| Cash Flow / Share | · | $-0.99 | · | · | · | $-0.47 | · | · | · | $-0.06 | · | · | $-0.31 | · | · | · | |
| Cash / Share | $1.08 | $1.02 | · | $0.89 | $0.30 | $0.34 | · | $0.45 | $0.40 | $1.77 | $0.37 | $0.69 | $0.23 | $0.38 | $0.21 | $0.16 | |
| EPS (TTM) | $-4.67 | $-4.15 | · | $-2.13 | $-1.54 | $-1.16 | · | $-0.92 | $-0.93 | $-0.92 | $-0.92 | $-0.90 | $-0.94 | $-0.81 | $-0.77 | $-0.74 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-535M | $-472M | · | $-237M | $-172M | $-128M | · | $-99M | $-97M | $-94M | $-81M | $-74M | $-72M | $-62M | $-59M | $-57M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -8.4 | -7.8 | · | -12.3 | -17.2 | -20.8 | · | -68.8 | -57.0 | -89.1 | -12.0 | -18.0 | -17.7 | -3.4 | -3.8 | -4.1 | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -12.0% | -12.8% | · | -8.1% | -5.8% | -4.8% | · | -1.5% | -1.8% | -1.1% | -8.3% | -5.5% | -5.7% | -29.8% | -26.6% | -24.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $0 | $0 | $0 | $0 |
| Beneficio neto | $-360M | $-110M | $-86M | $-69M | $-55M |
| EPS Diluido | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| Ratio Rápido | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
No hay datos para este estado
Aún no hay suficientes datos fundamentales para generar este estado.
Propietarios institucionales (13F) 499 declarantes · $3.8B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
499
Valor en tenencia
$3.8B
Nuevas posiciones
84
Posiciones cerradas
44
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 84 (+8 vs trimestre anterior) | 44 (-25 vs trimestre anterior) | 153 (-5 vs trimestre anterior) | 133 (+4 vs trimestre anterior) | +5.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $351 254 252 | 9 984 487 | 9,30% | Acciones |
| FMR LLC | $247 157 830 | 6 335 756 | 6,54% | Acciones |
| BlackRock, Inc. | $241 458 213 | 6 189 649 | 6,39% | Acciones |
| STATE STREET CORP | $218 705 430 | 5 606 394 | 5,79% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $197 143 394 | 5 053 663 | 5,22% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174 931 100 | 4 484 263 | 4,63% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $153 598 520 | 3 937 414 | 4,07% | Acciones |
| MORGAN STANLEY | $135 990 439 | 3 486 040 | 3,60% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113 382 565 | 2 906 500 | 3,00% | Opción de compra |
| AMERIPRISE FINANCIAL INC | $84 108 797 | 2 156 083 | 2,23% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $81 865 360 | 2 097 981 | 2,17% | Acciones |
| TWO SIGMA ADVISERS, LP | $74 906 241 | 2 129 228 | 1,98% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $70 844 186 | 1 816 050 | 1,88% | Acciones |
| D. E. Shaw & Co., Inc. | $62 649 826 | 1 605 994 | 1,66% | Acciones |
| DIADEMA PARTNERS LP | $47 623 408 | 1 220 800 | 1,26% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46 039 602 | 1 180 200 | 1,22% | Opción de venta |
| CITADEL ADVISORS LLC | $43 773 121 | 1 122 100 | 1,16% | Opción de compra |
| BNP PARIBAS FINANCIAL MARKETS | $38 296 117 | 981 700 | 1,01% | Acciones |
| CITADEL ADVISORS LLC | $37 118 600 | 951 515 | 0,98% | Acciones |
| GOLDMAN SACHS GROUP INC | $36 780 227 | 942 841 | 0,97% | Acciones |
| UBS Group AG | $36 515 505 | 936 055 | 0,97% | Acciones |
| JPMORGAN CHASE & CO | $36 387 793 | 915 185 | 0,96% | Acciones |
| JANE STREET GROUP, LLC | $35 091 757 | 899 558 | 0,93% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31 846 477 | 816 367 | 0,84% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $30 999 667 | 794 660 | 0,82% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $28 557 153 | 732 047 | 0,76% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28 504 217 | 730 690 | 0,75% | Acciones |
| Pictet Asset Management Holding SA | $26 640 280 | 682 909 | 0,71% | Acciones |
| Vestal Point Capital, LP | $26 526 800 | 680 000 | 0,70% | Acciones |
| NORTHERN TRUST CORP | $24 448 309 | 626 719 | 0,65% | Acciones |
| CITADEL ADVISORS LLC | $23 530 832 | 603 200 | 0,62% | Opción de venta |
| Eversept Partners, LP | $23 519 987 | 602 922 | 0,62% | Acciones |
| BlackBarn Capital Partners LP | $23 406 000 | 600 000 | 0,62% | Acciones |
| Jump Financial, LLC | $22 621 196 | 579 882 | 0,60% | Acciones |
| ADAR1 Capital Management, LLC | $22 393 222 | 574 038 | 0,59% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $21 067 468 | 540 053 | 0,56% | Acciones |
| JANE STREET GROUP, LLC | $20 870 350 | 535 000 | 0,55% | Opción de compra |
| Connor, Clark & Lunn Investment Management Ltd. | $20 698 979 | 530 607 | 0,55% | Acciones |
| Caption Management, LLC | $20 511 458 | 525 800 | 0,54% | Opción de compra |
| TANG CAPITAL MANAGEMENT LLC | $19 505 000 | 500 000 | 0,52% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $19 433 690 | 498 172 | 0,51% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $19 290 796 | 494 509 | 0,51% | Acciones |
| Point72 Asset Management, L.P. | $18 463 745 | 473 308 | 0,49% | Acciones |
| Clearbridge Investments, LLC | $17 350 907 | 444 781 | 0,46% | Acciones |
| DIADEMA PARTNERS LP | $17 234 930 | 441 808 | 0,46% | Acciones |
| BLAIR WILLIAM & CO/IL | $16 258 035 | 416 766 | 0,43% | Acciones |
| Bank of New York Mellon Corp | $15 909 848 | 407 840 | 0,42% | Acciones |
| ExodusPoint Capital Management, LP | $15 346 650 | 393 000 | 0,41% | Opción de compra |
| BANK OF AMERICA CORP /DE/ | $14 971 064 | 383 775 | 0,40% | Acciones |
| Walleye Trading LLC | $14 964 236 | 383 600 | 0,40% | Opción de compra |
Informantes de la empresa 17 insiders · 9 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | 29 de julio de 2026 S | 2 572 441 | 0 | 6 | $-14 005 897 |
| Greg Zante | Chief Financial Officer | 29 de julio de 2026 S | 212 204 | 0 | 6 | $-2 823 737 |
| Marianna Mancini | Chief Operating Officer | 29 de julio de 2026 S | 422 760 | 0 | 6 | $-2 727 473 |
| Michael Dinerman | Chief Operating Officer | 4 de mayo de 2015 C | 694 116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | 1 de junio de 2026 A | · | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | 10 de marzo de 2026 P | 4 475 | 1 | 0 | $149 912 |
| Michael Morneau | VP, Finance and Administration | 19 de enero de 2021 F | 116 062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | 3 de enero de 2019 A | 141 063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | 4 de mayo de 2016 F | 160 836 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | Consejero | 1 de agosto de 2026 A | 6 333 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | Consejero | 2 de enero de 2026 A | 4 390 | 0 | 0 | $0 |
| Lawson Macartney | Consejero | 2 de enero de 2026 A | 51 115 | 0 | 0 | $0 |
| Charles A Rowland Jr | Consejero | 2 de enero de 2026 A | 33 150 | 0 | 1 | $-2 134 200 |
| Matthew J Singleton | Consejero | 2 de enero de 2026 A | 12 650 | 0 | 0 | $0 |
| Matthew W Foehr | Consejero | 2 de enero de 2026 A | 135 186 | 0 | 1 | $-561 760 |
| Stephen W Webster | Consejero | 2 de enero de 2020 A | 8 000 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | Propietario del 10% | 26 de agosto de 2020 S | 5 819 383 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 45 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,78% | 121 599 NS | 31 de julio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,74% | 10 811 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 3 463 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,22% | 1 661 NS | 31 de julio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,15% | 4 217 NS | 31 de julio de 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,15% | 69 539 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 29 780 NS | 31 de julio de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,12% | 1 464 336 SH | 19 de agosto de 2026 | Diario |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 23 485 SH | 1 de octubre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,06% | 330 703 SH | 19 de agosto de 2026 | Diario |
| IYH · iShares Trust | 0,06% | 66 102 SH | 11 de septiembre de 2026 | Diario |
| ESML · iShares Trust | 0,06% | 50 114 SH | 11 de septiembre de 2026 | Diario |
| ISCG · iShares Trust | 0,05% | 16 143 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 52 319 NS | 31 de julio de 2026 | N-PORT |
| SMMD · iShares Trust | 0,05% | 60 016 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 1 332 828 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,05% | 2 530 231 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 38 051 SH | 1 de octubre de 2026 | Diario |
| IWS · iShares Trust | 0,03% | 156 686 SH | 11 de septiembre de 2026 | Diario |
| WSML · iShares Trust | 0,03% | 6 550 SH | 11 de septiembre de 2026 | Diario |
| IWR · iShares Trust | 0,03% | 462 379 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3 501 108 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19 254 SH | 19 de agosto de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 63 630 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9 458 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 48 216 NS | 31 de julio de 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 25 563 SH | 19 de agosto de 2026 | Diario |
| IWD · iShares Trust | 0,01% | 234 063 SH | 11 de septiembre de 2026 | Diario |
| REVS · Columbia ETF Trust I | 0,01% | 922 NS | 31 de julio de 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 46 707 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 158 911 SH | 11 de septiembre de 2026 | Diario |
| RECS · Columbia ETF Trust I | 0,01% | 9 430 NS | 31 de julio de 2026 | N-PORT |
| IWB · iShares Trust | 0,00% | 73 105 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 28 131 SH | 10 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 1 106 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9 683 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 044 NS | 31 de julio de 2026 | N-PORT |
| IWF · iShares Trust | 0,00% | 33 127 SH | 11 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 1 939 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 6 609 NS | 31 de julio de 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 92 569 SH | 19 de agosto de 2026 | Diario |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 830 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 4 916 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 12 964 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 40 261 SH | 11 de septiembre de 2026 | Diario |
VKTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 26 analistas
COMPRA
Objetivo mediano
$95.00
+217,3%
9 34,6%
Compra fuerte
14 53,8%
Compra
3 11,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
19 analistas · 2026-09-30Objetivo medio $94.82 +216,7%
← Por Debajo de Todos los Objetivos
Precio Actual $29.94
Mín$38.00
Media$94.82
Máx$125.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results
Yahoo Finance · 1 semana, 2 días atrás
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September
Nasdaq · 3 semanas, 1 día atrás
2 Beaten-Down Stocks With Massive Upside Potential
Nasdaq · 2 meses, 3 semanas atrás
Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
Nasdaq · 3 meses, 1 semana atrás
Is Viking Therapeutics Stock Going to $100?
Nasdaq · 3 meses, 3 semanas atrás
Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
Nasdaq · 3 meses, 3 semanas atrás
1 Razón por la que esta acción de biotecnología podría triplicarse antes de fin de año
Nasdaq · 6 meses atrás
¿Tienes $1,500? ¿Es Mejor Comprar Bitcoin o Viking Therapeutics?
Nasdaq · 6 meses, 1 semana atrás
Qué saber sobre este desarrollador de medicamentos para la obesidad que acaba de recibir una nueva inversión de $7 millones
Yahoo Finance · 6 meses, 2 semanas atrás
Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa
Ninguna señal abierta en este momento — ninguna tarjeta está completada, y eso es honesto.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 29, 2026